ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 628562 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 628562; 2) Community: the network communities that were significantly associated with the response to NSC 628562; 3) Molecule: the relationships between components within communities and NSC 628562; 4) MDR: the compounds that were significantly associated with the NSC 628562.

NSC Compound Enrichment Correlation
NSC 639187 Landomycin A 0.000751340623722758 0.59063084
NSC 653547 Null 0.000751340623722758 0.66860097
NSC 655748 Null 0.000751340623722758 0.4745847
NSC 657561 (Z)-4-bromo-4-iodo-3-phenyl-3-buten-2-one 0.000751340623722758 0.6830796
NSC 666592 Null 0.000751340623722758 0.60899693
NSC 702313 Null 0.000751340623722758 0.49566701
NSC 707465 2-Butenoic acid, 4-[[4,5-dichloro-2-[[[[2-(1-pyrrolidinyl)cyclohexyl] (methyl)amino]carbonyl]methyl]phenyl]amino]-4-oxo-, methyl ester, (1S,2S)- 0.000751340623722758 0.36574104
NSC 135037 Jatrophone 0.000837923650101964 0.6268169
NSC 363787 Kaur-16-en-15-one,1,3,7,11-tetrakis(acetyloxy)-12-hydroxy-, (1.alpha.,3.beta.,7.beta.,11.beta.,12.alpha.)- 0.000837923650101964 0.68698768
NSC 633113 [1,2,3,4]Tetrathiocino[5,6-d:7,8-d']diimidazole- 2,9-dithione, 1,3,8,10-tetraethyl-1,2,3,8,9,10-hexahydro- 0.000837923650101967 0.64908718
Total:111  Current:9    [First] [Prev] [Next] [Last]